Biogen Newsroom

S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today

Kevin Travers16:12 ET

Biogen Put Volume Heavy and Directionally Bearish

TipRanks11:15 ET

Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock

Kevin TraversNov 26 10:02 ET

Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials Driving The Negative Sentiment?

Simply Wall StNov 26 09:53 ET

Anavex Gains After Seeking EU Marketing Nod for Alzheimer's Drug

Seeking AlphaNov 26 08:55 ET

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250

Moomoo NewsNov 25 10:30 ET · Ratings

Jefferies Remains a Buy on Biogen (BIIB)

TipRanksNov 25 10:26 ET · Ratings

S&P 500, Dow Hit Records Right After Open | Live Stock

Kevin TraversNov 25 10:00 ET

Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?

BarchartNov 25 05:09 ET

Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC

Seeking AlphaNov 22 21:25 ET

Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day

Kevin TraversNov 22 16:17 ET

Market Climbs, Bitcoin Close to $100k | Live Stock

Kevin TraversNov 22 11:06 ET

Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock

Yahoo FinanceNov 22 07:45 ET

Biogen Price Target Lowered to $207 From $251 at Mizuho

Yahoo FinanceNov 22 06:45 ET

Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today

Kevin TraversNov 21 16:09 ET

Optimism Over Global Healthcare Sector Rises: Jefferies

Seeking AlphaNov 21 13:45 ET

Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock

Kevin TraversNov 21 10:53 ET

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207

BenzingaNov 21 08:08 ET · Ratings

Biogen Analyst Ratings

BenzingaNov 21 08:07 ET · Ratings

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $207

Moomoo NewsNov 21 07:31 ET · Ratings